Pages

Friday, March 18, 2016

Valeant's Specialty Pharma Kin Protest Too Much

Bloomberg-9 hours ago
A government investigation, M&A-driven debt loads, pharmacybenefit manager fights, and double-digit share price declines. Nope. Not talking about Valeant

No comments:

Post a Comment